Live Price
Live Volume
Chart Volume 0
Volume 0
5 secGalectin Therapeutics Market Segments
Regular Trading Hours
+0.11(+2.99%)
| Open | $3.68 |
|---|---|
| Close | $3.79 |
| Low | $3.66 |
| Low Change | -0.02 (-0.54%) |
| High | $3.84 |
| High Change | +0.16 (+4.35%) |
| Range | $0.18 |
| Volume | 56.855K |
| Dollar Volume | $215.48K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $3.64 |
|---|---|
| Close | $3.64 |
| Low | $3.64 |
| Low Change | 0.00 (0.00%) |
| High | $3.64 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 14.587K |
| Dollar Volume | $53.10K |
Regular Trading Hours Yesterday
-0.01(-0.27%)
| Open | $3.66 |
|---|---|
| Close | $3.65 |
| Low | $3.61 |
| Low Change | -0.05 (-1.37%) |
| High | $3.86 |
| High Change | +0.20 (+5.46%) |
| Range | $0.25 |
| Volume | 381.967K |
| Dollar Volume | $1.39M |
Premarket Yesterday
*No Trades in Segment
Galectin Therapeutics News
Galectin Therapeutics Top Trades
Galectin Therapeutics's top trade so far today returned +4.35%, while the top short trade returned -1.30%.
Galectin Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.76 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.76 |
| 20 Day Moving Average (SMA20) | $3.85 |
| 50 Day Moving Average (SMA50) | $3.80 |
| 100 Day Moving Average (SMA100) | $3.62 |
| 200 Day Moving Average (SMA200) | $3.22 |
Galectin Therapeutics Statistics
| Average Volume (30 Days) | 298.79K |
|---|---|
| P/E Ratio (Current) | -14.07 |
| EPS (Current) | -$0.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$15.89M |
| Cash Ratio | 0.09 |
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt to Equity | -0.24 |
| Enterprise Value | $417.12M |
| EV to EBITDA | -26.70 |
| EV to Sales | — |
| Price to Book | -2.87 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -1.89% |
| Return on Equity | 0.20% |
Galectin Therapeutics Stock Splits
There has been 1 stock split for Galectin Therapeutics (GALT). The reverse stock split occured on March 23, 2012 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 23, 2012 | Reverse | 6:1 |
Galectin Therapeutics Dividends
There have been no dividends for Galectin Therapeutics (GALT).